Multiple Sclerosis, Acute Relapsing: Clinical Trials

3 completed. 1 Phase 1, 1 Phase 3.

By phase and status

Phase	Trials	Status
Phase 1	1	Completed 1
Phase 3	1	Completed 1

Follow Multiple Sclerosis, Acute Relapsing: new trials by email Literature Review of Multiple Sclerosis, Acute Relapsing trials Research Report on Multiple Sclerosis, Acute Relapsing

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis blood sampling - Multiple Sclerosis, Acute Relapsing, Multiple Sclerosis		Completed	Centre Hospitalier Régional d'Orléans	78	2020-09-07	2022-02-17
An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis Immediately Following a Relapse rHIgM22, Placebo - Multiple Sclerosis, Acute Relapsing	Phase 1	Completed	Acorda Therapeutics	27	2015-04-01	2018-08-22
Plasma Exchanges in Multiple Sclerosis (MS) Relapses plasma exchange, sham exchanges procedure - Multiple Sclerosis, Multiple Sclerosis, Acute Relapsing	Phase 3	Completed	University Hospital, Bordeaux	38	2012-03-08	2026-05-14

Narrower conditions

Multiple Sclerosis, Relapsing-Remitting (3)  ·  Multiple Sclerosis (2)  ·  Inflammation (1)

Broader conditions

Autoimmune Diseases (3)  ·  Autoimmune Diseases of the Nervous System (3)  ·  Demyelinating Autoimmune Diseases, CNS (3)  ·  Demyelinating Diseases (3)  ·  Immune System Diseases (3)  ·  Nervous System Diseases (3)  ·  Multiple Sclerosis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Blood Specimen Collection (1)  ·  Plasma Exchange (1)

Sponsors

Acorda Therapeutics (1)  ·  Centre Hospitalier Régional d'Orléans (1)  ·  University Hospital, Bordeaux (1)

Countries

France (2)  ·  United States (1)

Results publications

PMID 22441536, PMID 29719048, PMID 31892309, PMID 32369661, PMID 35496758